Pharmaceuticals and Biopharmaceuticals

Partech is a global investment platform for tech and digital companies. 

P1 Ventures is a venture capital firm that specializes in early-stage industrial technology firms in Africa.

Consonance Investment Managers is an investment company focused on helping early and growth-stage entrepreneurs build enduring companies in Africa.

As a crucial part of its expansion plan, AAIC Investment, a renowned consulting organization, has introduced the African Healthcare and Africa Innovation & Healthcare Fund. Through enabling mergers and acquisitions, the fund seeks to encourage corporate growth in developing nations and novel industries. Through the establishment of worldwide Angle, a research organization with over 170 local researchers in 80 countries, AAIC Investment also helps corporate growth through worldwide networks and human resources.

Aruwa Capital Management is a Lagos-based, female-founded and led, growth equity, impact investment company. 

Aruwa Capital Management invests in companies that have strong management teams and meet the following criteria:

• Provides essential goods and services that cater to women.
• Founded or co-founded by a woman, has women within its workforce, senior management team or value chain.
• A positive attitude towards and active support of a diverse team.
• An annual turnover of at least $300-500k.
• Proven management team with a history of delivering the underlying business plan.

Biotechnology company pioneering microbiome-based precision personal care product research development and commercialisation for disease prevention and health promotion. Dedicated to expanding access of the African public to microbiome mapping and driving the industry towards microbiome conserving formulating in personal care items.

API BIO develops innovative functional molecules with impactful applications in healthcare, bioremediation and agriculture.

Our molecules are derived from high-burden land-fill waste as well as other sources of organic waste from various food and manufacturing industries. Our innovations align with the following Sustainable development goals (SDG) 1, 2, 3, 6, 11, 12, 13 & 15.

We also develop Aptamer-linked molecules for highly specific and accurate diagnostic methods, efficient drug delivery, pathogen specific targeting as well as non-toxic chelates molecules designed for bioremediation.